These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30288432)

  • 1. Evidenced-Based Claims About Evidence.
    Howard DH
    MDM Policy Pract; 2017; 2(2):2381468317734527. PubMed ID: 30288432
    [No Abstract]   [Full Text] [Related]  

  • 2. PASSCLAIM - Synthesis and review of existing processes.
    Richardson DP; Affertsholt T; Asp NG; Bruce A; Grossklaus R; Howlett J; Pannemans D; Ross R; Verhagen H; Viechtbauer V
    Eur J Nutr; 2003 Mar; 42 Suppl 1():I96-111. PubMed ID: 12664324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiropractic claims in the English-speaking world.
    Ernst E; Gilbey A
    N Z Med J; 2010 Apr; 123(1312):36-44. PubMed ID: 20389316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA perspectives on health claims for food labels.
    Rowlands JC; Hoadley JE
    Toxicology; 2006 Apr; 221(1):35-43. PubMed ID: 16480811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claims in advertisements for antihypertensive drugs in a Dutch medical journal.
    Greving JP; Denig P; de Zeeuw D; Haaijer-Ruskamp FM
    J Hypertens; 2007 Mar; 25(3):713-22. PubMed ID: 17278989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claim validity of print advertisements found in otolaryngology journals.
    Del Signore A; Murr AH; Lustig LR; Platt MP; Jalisi S; Pratt LW; Spiegel JH
    Arch Otolaryngol Head Neck Surg; 2011 Aug; 137(8):746-50. PubMed ID: 21576549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the US Food and Drug Administration evaluates the scientific evidence for health claims.
    Ellwood KC; Trumbo PR; Kavanaugh CJ
    Nutr Rev; 2010 Feb; 68(2):114-21. PubMed ID: 20137056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting qualified health claims: evidence from experimental studies.
    Hooker NH; Teratanavat R
    Crit Rev Food Sci Nutr; 2008 Feb; 48(2):160-76. PubMed ID: 18274970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology-driven interactive care management identifies and resolves more clinical issues than a claims-based alerting system.
    Juster IA
    Dis Manag; 2005 Jun; 8(3):188-97. PubMed ID: 15966784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population.
    Wahl PM; Terrell DR; George JN; Rodgers JK; Uhl L; Cataland S; Bohn RL
    Thromb Haemost; 2010 Jun; 103(6):1203-9. PubMed ID: 20352159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How is research evidence used to support claims made in advertisements for wound care products?
    Dumville JC; Petherick ES; O'Meara S; Raynor P; Cullum N
    J Clin Nurs; 2009 May; 18(10):1422-9. PubMed ID: 18717743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials.
    Brennan JM; Wruck L; Pencina MJ; Clare RM; Lopes RD; Alexander JH; O'Brien S; Krucoff M; Rao SV; Wang TY; Curtis LH; Newby LK; Granger CB; Patel M; Mahaffey K; Ross JS; Normand SL; Eloff BC; Caños DA; Lokhnygina YV; Roe MT; Califf RM; Marinac-Dabic D; Peterson ED
    Am Heart J; 2019 Dec; 218():110-122. PubMed ID: 31726314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of School-Based Educational Interventions for Enhancing Adolescents Abilities in Critical Appraisal of Health Claims: A Systematic Review.
    Nordheim LV; Gundersen MW; Espehaug B; Guttersrud Ø; Flottorp S
    PLoS One; 2016; 11(8):e0161485. PubMed ID: 27557129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASSESSING THE VALUE OF INNOVATIVE MEDICAL DEVICES AND DIAGNOSTICS: THE IMPORTANCE OF CLEAR AND RELEVANT CLAIMS OF BENEFIT.
    Campbell B; Campbell M; Dobson L; Higgins J; Dillon B; Marlow M; Pomfrett CJD
    Int J Technol Assess Health Care; 2018 Jan; 34(4):419-424. PubMed ID: 30025548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USING CLAIMS DATA FOR EVIDENCE GENERATION IN MANAGED ENTRY AGREEMENTS.
    Brandes A; Schwarzkopf L; Rogowski WH
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):69-77. PubMed ID: 26975757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Resource Use, Costs, and Diagnosis Patterns in Patients With Schizophrenia and Bipolar Disorder: Real-world Evidence From US Claims Databases.
    Broder MS; Greene M; Chang E; Hartry A; Touya M; Munday J; Yan T
    Clin Ther; 2018 Oct; 40(10):1670-1682. PubMed ID: 30193748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Hoffman V; Xue F; Gardstein B; Skerry K; Critchlow CW; Enger C
    Osteoporos Int; 2016 Apr; 27(4):1653-1658. PubMed ID: 26558380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Emergency Department Visits in Medicare Administrative Claims: Approaches and Implications.
    Venkatesh AK; Mei H; Kocher KE; Granovsky M; Obermeyer Z; Spatz ES; Rothenberg C; Krumholz HM; Lin Z
    Acad Emerg Med; 2017 Apr; 24(4):422-431. PubMed ID: 27864915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation.
    Stewart KA; Neumann PJ
    Value Health; 2002; 5(5):390-7. PubMed ID: 12201856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.